Topic: GlaxoSmithKline plc
OAKLAND, California (Reuters) - A U.S. jury rejected GlaxoSmithKline's antitrust claims against Abbott Laboratories over allegations of unfair HIV drug pricing, after Britain's biggest drugmaker had asked for hundreds of millions in damages.Glaxo accused Abbott of improperly hiking the price of one ...
Positive Antiviral Responses Demonstrated in Interim 16 Week Analysis from SPRING-1 Study Antiviral activity shown by S/GSK1349572 in treatment-experienced subjects resistant to raltegravir from VIKING Study. Shionogi-ViiV Healthcare LLC today reported data from two Phase IIb studies showing that its once-daily, unboosted ...
LONDON (Reuters) - GlaxoSmithKline and its partner Shionogi are progressing a new drug against HIV into final-stage clinical testing, ramping up competition in a class of AIDS drugs known as integrase inhibitors.The two drugmakers said on Wednesday they would be progressing the ...
LONDON (Reuters) - GlaxoSmithKline plans to invest up to 60 million pounds ($97 million) over 10 years to improve research, development and access to AIDS drugs in Africa, the world's second biggest drugmaker said on Tuesday.It has also agreed a new free ...
British drugmaker GlaxoSmithKline is teaming up with American rival Pfizer to secure a fifth of the market for treatments against the HIV virus, helping to contain Glaxo's falling HIV drug sales and paving the way for similar arrangements in the pharmaceutical sector. ...
Pharmaceutical giants GlaxoSmithKline PLC and Pfizer Inc. will pool resources to create a new company to develop and sell HIV medicines, leveraging a small investment into the No. 2 market position.The deal, announced Thursday, reflects two trends sweeping the industry. Companies are ...
Patient advocates are complaining that GlaxoSmithKline is using scary advertising to market medicines for HIV, the deadly virus that causes AIDS. " Some of Glaxo's biggest HIV drugs have been losing ground to newer treatments, and AIDS groups say the ads appear ...
GlaxoSmithKline, one of the world's biggest makers of HIV drugs, said it is cutting prices of its HIV drugs in the world's poorest countries, marking its fifth rollback since 1997.. Glaxo sells its HIV drugs at cost in 64 of the world's ...
Photo Gallery
From Around the Web
Video Gallery
-
News Update: New Study Shows GlaxoSmithKline ...
A study in the Journal of the American Medical Association ...2010-06-28 -
GlaxoSmithKline up 1%; Pronova Biopharma Settles ...
GlaxoSmithKline plc (GSK) shares are up 0.89% to $38 ...2011-03-30 -
GlaxoSmithKline Plc (GSK)
Everyone is looking for a nice save haven in these ...2008-02-13
